Flash talks on angioedema
Flash talks on angioedema
Efficacy and safety of lanadelumab in pediatric patients aged 2 to <12 years: subgroup analyses from the SPRING Study
00:00
00:00
Efficacy and Safety of Oral Administered Bradykinin B2 Receptor Inhibitor PHVS416 in Treatment of Hereditary Angioedema Attacks: Topline Results of RAPIDe-1 Phase 2 Trial
00:00
00:00
Real-world Burden of Illness in Patients with Hereditary Angioedema Type I and II
00:00
00:00
Burden of hereditary angioedema: Findings from a multinational patient survey in Argentina and Colombia
00:00
00:00
Burden of hereditary angioedema: Findings from a multinational survey of caregivers for pediatric and adult patients in Argentina and Colombia
00:00
00:00
The impact of puberty on onset, frequency, location and severity of attacks in Hereditary Angioedema due to C1-inhibitor deficiency: a survey from the Italian Network for Hereditary and Acquired Angioedema (ITACA)
00:00
00:00